Who to call at Phio Pharmaceuticals Corp., and when
Fundz watches for the moments Phio Pharmaceuticals Corp. starts buying, and tells you who to reach.
- An alert the day Phio Pharmaceuticals Corp. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Phio Pharmaceuticals Corp., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Phio Pharmaceuticals Corp.. With Fundz connected, it knows.
Phio Pharmaceuticals Corp.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
phiopharma.comAI Executive Summary
AI-powered analysis of 8-K filing content
Phio Pharmaceuticals announced that director Robert Ferrara resigned effective immediately on October 31, 2025, including his Lead Independent Director role and his seats on the Compensation and Audit Committees. The Board reduced its size from six to five members, and David Deming was named Lead Independent Director.
Key Takeaways
Robert Ferrara resigned effective immediately from the Board, the Compensation Committee, and the Audit Committee, and gave up the Lead Independent Director role.
The filing states Ferrara's resignation was not the result of any disagreement with the Company.
3 more takeaways
Filing Overview
What This Means
Phio Pharmaceuticals Corp. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.